Immunculus as an Approach for the Evaluation of Multiple Sclerosis: A Case Report
Mir Hadi Jazayeri
Abstract
Open-access reader
Mir Hadi Jazayeri
Abstract
Open-access reader
Fingolimod is the first agent used for the treatment of relapsing-remitting multiple sclerosis. Here we report a case, who was diagnosed with multiple sclerosis, after receiving fingolimod treatment feels well except mild tingling in his hands and feet. >
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Fingolimod is the first agent used for the treatment of relapsing-remitting multiple sclerosis. Here we report a case, who was diagnosed with multiple sclerosis, after receiving fingolimod treatment feels well except mild tingling in his hands and feet. >
Key concepts: Fingolimod, Multiple sclerosis, Relapsing remitting, Medicine, Tingling, Dermatology, Surgery, Immunology